Science Inc. | Life Sciences Fall 2025 Demo Day
December 11 @ 1:30 pm – 6:30 pm
The Innovation Space
200 Powder Mill Rd, Bldg E500
Wilmington, DE 19803
This live hybrid event marks the culmination of our Fall 2025 accelerator, featuring pitches from early-stage startups developing breakthroughs in biotechnology, therapeutics, diagnostics and drug delivery.
Agenda
1:00 PM — Doors Open (In-Person Only)
1:30–4:30 PM — Startup Pitches (In-Person + Virtual)
4:30–6:30 PM — Networking Happy Hour (In-Person Only)
This event is invite only, contact us if you are interested in attending.
Meet the Companies:
Ajaya Bio is engineering precision antibodies that remove disease-causing immune cells while sparing healthy ones.
Antelope Surgical Solutions, Inc. is advancing the first PSMA-targeted fluorescent and radioligand agent for real-time cancer surgery, imaging, and therapy.
APASOMICS is developing precision drug delivery systems for bone treatments, targeting hard-to-reach tissues with controlled, prolonged release, enhancing efficacy and minimizing systemic side effects.
ClearVision Therapeutics, Inc. is developing the 1st RNA cure to stop genetic corneal diseases, improve corneal function and decrease dependence on transplants.
Ex-Amplify Therapeutics is building a “once and done” gene therapy for migraine pain that targets an unexplored calcium channel, with AI/ML-backed gene therapy cargo design enabling activation under migraine trigger.
HeraNano Therapeutics is developing safe, effective, and accessible nanoparticle drug delivery systems to address critical unmet needs in women’s health.
Larada Therapeutics, Inc. is advancing treatment for rare ocular diseases that currently have no approved therapies.
LisenID is utilizing epigenetic imprinting biomarkers and AI to eliminate indeterminate tumors and enable providers to make confident, doubt free diagnoses.
Livestock Labs is engineering high-performance animal cells that enable food companies to grow real meat — without the animal — faster, cheaper, and at scale.
Riboway Therapeutics is developing RNA-targeted therapeutics to make every protein druggable, enabling precise control of protein expression and function through leveraging AI to decode RNA biology.